Share this article on:

Consideration of Native Coronary Disease Progression in the Decision to Perform Hybrid Coronary Revascularization

Rodriguez, Maria L. MD; Glineur, David MD, PhD; Ruel, Marc MD, MPH

Innovations:Technology and Techniques in Cardiothoracic and Vascular Surgery: January/February 2017 - Volume 12 - Issue 1 - p 1–3
doi: 10.1097/IMI.0000000000000332
Editorial

From the University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Accepted for publication November 24, 2016.

Disclosures: Marc Ruel, MD, MPH, is a proctor for Medtronic, Inc, Minneapolis, MN USA. Maria L. Rodriguez, MD, and David Glineur, MD, PhD, declare no conflicts of interest.

Address correspondence and reprint requests to Maria L. Rodriguez, MD, University of Ottawa Heart Institute, Suite 3402, 40 Ruskin St, Ottawa, ON Canada K1Y 4W7. E-mail: mrodriguez@cheo.on.ca.

©2017 by the International Society for Minimally Invasive Cardiothoracic Surgery